Aileron Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Aileron Therapeutics's estimated annual revenue is currently $3.3M per year.
- Aileron Therapeutics's estimated revenue per employee is $232,500
- Aileron Therapeutics's total funding is $218.2M.
Employee Data
- Aileron Therapeutics has 14 Employees.
- Aileron Therapeutics grew their employee count by -53% last year.
Aileron Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | COO and President | Reveal Email/Phone |
2 | SVP Research | Reveal Email/Phone |
3 | Analyst | Reveal Email/Phone |
4 | President and CEO | Reveal Email/Phone |
5 | Corporate Controller | Reveal Email/Phone |
6 | Interim CFO | Reveal Email/Phone |
Aileron Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Aileron Therapeutics?
Aileron Therapeutics is an emerging biopharmaceutical company that is applying its proprietary cell permeable peptide technology to generate breakthrough therapeutics for the treatment of cancer and other diseases. Aileron's technology is the first and only process that allows peptides to penetrate cells in a sequence-independent manner. Aileron is developing the first generation of peptide therapeutics directed at intra-cellular protein-protein interaction targets that are not addressable by small molecule or biological drugs.
keywords:N/A
$218.2M
Total Funding
14
Number of Employees
$3.3M
Revenue (est)
-53%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aileron Therapeutics News
... Segments, Future Trends and Forecast 2028 | Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Merck KGaA, Aileron Therapeutics.
... Segments, Future Trends and Forecast 2028 | Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Merck KGaA, Aileron Therapeutics.
As a group, equities research analysts forecast that Aileron Therapeutics will post -0.33 EPS for the current fiscal year.
A number of analysts recently weighed in on the stock. William Blair reaffirmed an outperform rating on shares of Aileron Therapeutics in a...
Other Companies in Watertown Town
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.5M | 32 | 3% | N/A |
#2 | $15.8M | 63 | 31% | N/A |
#3 | $19.8M | 68 | -9% | N/A |
#4 | $6.9M | 75 | 6% | N/A |
#5 | $9.3M | 93 | 6% | N/A |